Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Monovalent and Multivalent RNA-based Vaccines in Healthy Subjects

NCT05004181 is registered in ClinicalTrials.gov with BioNTech SE as lead sponsor.

NCT NCT05004181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05004181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Monovalent and Multivalent RNA-based Vaccines in Healthy Subjects
Lead sponsor
BioNTech SE
Phase
Phase 2
Overall status
Completed
Start date
August 25, 2021
Completion date
October 4, 2023
Enrollment
1,380 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars (disease), sars-cov-2 acute respiratory disease, sars-cov-2 infection